{"disease":{"id":"thrombocytopenia","name":"thrombocytopenia"},"drugs":{"marketed":[{"drug_id":"efgartigimod","indication_name":"Immune thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Efgartigimod","company_name":"M. Peter Marinkovich","drug_phase":"marketed","molecular_target":"FcRn","drug_class":"Endoglycosidase [EPC]","quality_score":58,"revenue":"2500","mechanism":"Efgartigimod alfa binds to FcRn, reducing circulating IgG, while hyaluronidase increases subcutaneous permeability."},{"drug_id":"efgartigimod-alfa","indication_name":"Immune thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vyvgart","generic_name":"EFGARTIGIMOD ALFA","company_name":"Argenx Bv","drug_phase":"marketed","molecular_target":"IgG receptor FcRn large subunit p51","drug_class":"Endoglycosidase [EPC]","quality_score":70,"revenue":"2500","mechanism":"Vyvgart works by binding to the p51 subunit of the FcRn receptor, preventing it from recycling antibodies back into the bloodstream."},{"drug_id":"eltrombopag","indication_name":"Thrombocytopenia in Chronic Hepatitis C","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Promacta","generic_name":"ELTROMBOPAG","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Thrombopoietin receptor","drug_class":"Thrombopoietin Receptor Agonist","quality_score":80,"revenue":"569","mechanism":"Promacta works by binding to the thrombopoietin receptor, stimulating platelet production in the bone marrow."},{"drug_id":"rilzabrutinib","indication_name":"persistent or chronic immune thrombocytopenia (ITP)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wayrilz","generic_name":"RILZABRUTINIB","company_name":"Genzyme Corp","drug_phase":"marketed","molecular_target":"","drug_class":"Kinase Inhibitor [EPC]","quality_score":48,"revenue":null,"mechanism":"Wayrilz works by blocking a specific enzyme that helps platelet-destroying immune cells function."},{"drug_id":"hydrocortisone-succinate","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"argatroban","indication_name":"Thrombosis Prevention in Heparin-Induced Thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Argatroban","generic_name":"ARGATROBAN","company_name":"Hikma Pharm Co Ltd","drug_phase":"marketed","molecular_target":"Prothrombin","drug_class":"Anti-coagulant [EPC]","quality_score":63,"revenue":null,"mechanism":"Argatroban works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process."},{"drug_id":"argatroban","indication_name":"Thrombosis in Heparin Induced Thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Argatroban","generic_name":"ARGATROBAN","company_name":"Hikma Pharm Co Ltd","drug_phase":"marketed","molecular_target":"Prothrombin","drug_class":"Anti-coagulant [EPC]","quality_score":63,"revenue":null,"mechanism":"Argatroban works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process."},{"drug_id":"hydrocortisone-acetate","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-acetate","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"prednison","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednison","company_name":"Wen Zhang","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"hydrocortisone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"prednisone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"nipent","indication_name":"Hairy cell leukemia patients with thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nipent","generic_name":"Pentostatin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Adenosine deaminase (ADA)","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"fostamatinib","indication_name":"Immune thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavalisse","generic_name":"FOSTAMATINIB","company_name":"Rigel Pharms","drug_phase":"marketed","molecular_target":"Receptor-type tyrosine-protein kinase FLT3","drug_class":"","quality_score":65,"revenue":null,"mechanism":"Tavalisse works by blocking the activity of the FLT3 enzyme, which is involved in the production of platelets."},{"drug_id":"lepirudin","indication_name":"Thrombosis in Heparin Induced Thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Refludan","generic_name":"LEPIRUDIN","company_name":"","drug_phase":"marketed","molecular_target":"Prothrombin","drug_class":"Anti-coagulant","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"betamethasone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"cortisol","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisone","indication_name":"Secondary thrombocytopenia in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"methylprednisolon","indication_name":"Acquired thrombocytopenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"dexamethasone-phosphate","indication_name":"Secondary thrombocytopenia in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"fostamatinib","indication_name":"Thrombocytopenia in Chronic ITP","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavalisse","generic_name":"FOSTAMATINIB","company_name":"Rigel Pharms","drug_phase":"marketed","molecular_target":"Receptor-type tyrosine-protein kinase FLT3","drug_class":"","quality_score":65,"revenue":null,"mechanism":"Tavalisse works by blocking the activity of the FLT3 enzyme, which is involved in the production of platelets."}],"pipeline":[],"offLabel":[],"totalMarketed":27,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05095844","title":"National Vaccine Adverse Event Reporting Survey and Etiology","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Neuroganics LLC","has_results":false},{"nct_id":"NCT05345561","title":"Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia","phase":"","overall_status":"COMPLETED","enrollment_count":14390,"lead_sponsor_name":"Rallybio","has_results":false},{"nct_id":"NCT03820960","title":"Risk Factors for Thrombosis in Immune Thrombocytopenia","phase":"","overall_status":"COMPLETED","enrollment_count":10039,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04067375","title":"Towards Routine HPA-screening In Pregnancy to Prevent FNAIT","phase":"","overall_status":"COMPLETED","enrollment_count":3660,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT05937828","title":"OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT05688306","title":"To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":3494,"lead_sponsor_name":"Liaoning Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06676904","title":"Neonatal Platelet Transfusion Threshold Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":2433,"lead_sponsor_name":"NICHD Neonatal Research Network","has_results":false},{"nct_id":"NCT07068425","title":"Longitudinal Observational Study on Immune Thrombocytopenia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03815175","title":"XIENCE 28 USA Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1605,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT05634005","title":"Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence","phase":"NA","overall_status":"COMPLETED","enrollment_count":1543,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT06011902","title":"A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT03835598","title":"Post-Operative Thrombocytopenia After Bio-prosthesis Implantation","phase":"","overall_status":"COMPLETED","enrollment_count":1233,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT06053021","title":"Antiplatelet Therapy for AIS Patients With Thrombocytopenia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05333861","title":"An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1150,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06043050","title":"PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia","phase":"","overall_status":"COMPLETED","enrollment_count":1042,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT03355742","title":"XIENCE 28 Global Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":963,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT05396157","title":"Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":813,"lead_sponsor_name":"Mount Sinai Hospital, Canada","has_results":false},{"nct_id":"NCT03110887","title":"Monitoring Outcome in Neonatal Thrombocytopenia","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research","has_results":false},{"nct_id":"NCT05522465","title":"Short-course High-dose Prednisone and Dexamethasone in Children With ITP","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":608,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT05520892","title":"Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":580,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT02783313","title":"Pathogen Reduction Evaluation & Predictive Analytical Rating Score","phase":"NA","overall_status":"COMPLETED","enrollment_count":567,"lead_sponsor_name":"Sanquin Research & Blood Bank Divisions","has_results":false},{"nct_id":"NCT07268898","title":"National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06187831","title":"Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Thomas Kander","has_results":false},{"nct_id":"NCT07070193","title":"Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06556888","title":"Observatory of Immunological Thrombopenic Purpura in the Brest Region","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04915287","title":"Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":476,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05861297","title":"Immune Thrombocytopenia Management in Adults","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":467,"lead_sponsor_name":"Nahda University","has_results":false},{"nct_id":"NCT05585463","title":"Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)","phase":"","overall_status":"COMPLETED","enrollment_count":460,"lead_sponsor_name":"Fundació Sant Joan de Déu","has_results":false},{"nct_id":"NCT05095896","title":"The Serum Lipid Profiles in ITP: a Retrospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":457,"lead_sponsor_name":"Ming Hou","has_results":false},{"nct_id":"NCT04155775","title":"Effects of a Platelet Transfusion Best Practices Alert","phase":"NA","overall_status":"COMPLETED","enrollment_count":446,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT02964325","title":"Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia","phase":"NA","overall_status":"TERMINATED","enrollment_count":422,"lead_sponsor_name":"Terumo BCTbio","has_results":true},{"nct_id":"NCT00508820","title":"An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":407,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07442513","title":"Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":404,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT05604859","title":"Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Qin Ning","has_results":false},{"nct_id":"NCT03617965","title":"Mortality Due to Septic Shock Associated With Thrombocytopenia","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Universidad de Guanajuato","has_results":false},{"nct_id":"NCT03767803","title":"Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women","phase":"","overall_status":"UNKNOWN","enrollment_count":344,"lead_sponsor_name":"Progenity, Inc.","has_results":false},{"nct_id":"NCT06223607","title":"Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT03288441","title":"Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT07298733","title":"The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06408324","title":"Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe","phase":"","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"European Research Consortium on ITP","has_results":false},{"nct_id":"NCT04968899","title":"IgIV Plus Prednisone vs High-dose Dexamethasone for ITP","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":272,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05029635","title":"Phase III Study on HMPL-523 for Treatment of ITP","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":272,"lead_sponsor_name":"Hutchison Medipharma Limited","has_results":false},{"nct_id":"NCT06809101","title":"Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.","phase":"","overall_status":"RECRUITING","enrollment_count":265,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT05459649","title":"Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":253,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT00614523","title":"Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04598750","title":"The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05944458","title":"Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Helwan University","has_results":false},{"nct_id":"NCT07408648","title":"A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":244,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}